- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03011801
Reducing Fetal Exposure to Maternal Depression to Improve Infant Risk Mechanisms
February 10, 2021 updated by: University of Illinois at Urbana-Champaign
This study evaluates Interpersonal Therapy (IPT) in the treatment of depression among pregnant women with elevated depressive symptoms.
Half of the women will be randomized to receive IPT, and the other half will get Treat As Usual, provided via behavioral health in the hospital.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Exposure to maternal depressive symptoms is one of the most well established risk factors for the development of later child psychopathology.
Accumulating evidence from naturalistic observational studies documents that fetal exposure to maternal depressive symptoms is associated with risk for later child mental health problems.
Maternal depression is one of the most common prenatal complications with approximately 40% of women experiencing elevated levels of depressive symptoms.
The majority of past research has been correlational, so potential causal conclusions have been limited.
This project will break new ground by testing the hypothesis that manipulating maternal depressive symptoms will benefit infant outcomes.
In this project, maternal depressive symptoms will be reduced using brief interpersonal therapy (IPT), a well-established and efficacious treatment, and testing whether this reduction leads to an improvement in the development of infant mechanisms associated with risk for later psychopathology.
The investigators propose to assess 300 pregnant women who report elevated levels of depressive symptoms and their infants.
Prior to the intervention, maternal measures of depressive symptoms will be collected.
Then half of the women will be randomized to receive IPT and the other half will receive enhanced usual care (TAU).
After completion of the intervention, maternal measures will be collected longitudinally through 14 months postpartum.
Infants will be evaluated at birth and two other times.
Infants will be assessed across four units of analysis (brain structure and function, physiology, behavior, and maternal-report).
Study Type
Interventional
Enrollment (Anticipated)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80208
- Recruiting
- University of Denver
-
Contact:
- Elysia Davis, PhD
- Phone Number: 303-871-3790
- Email: Elysia.Davis@du.edu
-
-
Illinois
-
Urbana, Illinois, United States, 61801
- Enrolling by invitation
- University of Illinois
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Adult women (over 18 years of age)
- A singleton intrauterine pregnancy
- English speaking
- Elevated depressive symptoms based on screening with the Edinburgh Postnatal Depression Scale (EPDS) with score > 9
Exclusion Criteria:
- Bipolar disorder and psychosis based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-NP)
- Current psychotropic medication use or current CBT/IPT usage
- An HPA axis or an endocrine disorder
- Maternal substance use [assessed using maternal report and urine toxicology
- Corticosteroid medication use during this pregnancy
- Invitto fertilization
- Presence of cervical or uterine abnormalities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral: Interpersonal Therapy
Individual psychotherapy that includes an initial engagement session and a total of 8 sessions.
IPT focuses on psychoeducation and interpersonal skill building to decrease interpersonal conflict and increase interpersonal support and competence.
|
reducing conflict in relationships, increasing social support in relationships, improving communication, reducing depressive symptoms
Other Names:
|
Placebo Comparator: Enhanced Usual Care
Maternity support services (MSS) is the usual standard of care for pregnant women.
A multi-disciplinary team of obstetric care providers routinely screen women for possible depression diagnosis.
If a woman screens positive, she is seen by a behavioral health specialist (BHS) for further assessment and to initiate treatment, if necessary.
The goals of MSS include offering services to promote healthy pregnancies and positive birth and parenting outcomes, including integrating mental health and prenatal care.
Women with elevated depressive symptoms are seen by BHS throughout the pregnancy and postpartum period and then bridged to mental health treatment.
BHS provides eclectic-based care but does not provide IPT.
|
Treatment as Usual, including eclectic and supportive therapy, as well as psychiatric medication
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of a Major Depressive Episode on SCID interview
Time Frame: 12 months post pregnancy
|
Presence of a depression diagnosis as measured by a semi-structured diagnostic evaluation
|
12 months post pregnancy
|
Symptom Checklist 20 (SCL20)
Time Frame: post intervention (approximately 2-3 months post baseline)
|
Self reported Depression Scores.
higher scores=more depression
|
post intervention (approximately 2-3 months post baseline)
|
Symptom Checklist 20 (SCL20)
Time Frame: 6 months post intervention
|
Self reported Depression Scores.
higher scores=more depression
|
6 months post intervention
|
Symptom Checklist 20 (SCL20)
Time Frame: 12 months post intervention
|
Self reported Depression Scores.
higher scores=more depression
|
12 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: post intervention (approximately 2-3 months post baseline)
|
Self reported Depression Scores.
higher scores=more depression
|
post intervention (approximately 2-3 months post baseline)
|
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: 6 months post intervention
|
Self reported Depression Scores.
higher scores=more depression
|
6 months post intervention
|
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: 12 months post intervention
|
Self reported Depression Scores.
higher scores=more depression
|
12 months post intervention
|
Work and Social Adjustment Scale (WSAS)
Time Frame: post intervention (approximately 2-3 months post baseline)
|
general maternal functioning
|
post intervention (approximately 2-3 months post baseline)
|
Work and Social Adjustment Scale (WSAS)
Time Frame: 6 month post intervention
|
general maternal functioning
|
6 month post intervention
|
Work and Social Adjustment Scale (WSAS)
Time Frame: 12 month post intervention
|
general maternal functioning
|
12 month post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Anticipated)
June 30, 2022
Study Completion (Anticipated)
December 28, 2022
Study Registration Dates
First Submitted
January 4, 2017
First Submitted That Met QC Criteria
January 4, 2017
First Posted (Estimate)
January 5, 2017
Study Record Updates
Last Update Posted (Actual)
February 15, 2021
Last Update Submitted That Met QC Criteria
February 10, 2021
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MH109662
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
NIMH Data Archive
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Lawson Health Research InstituteTerminated
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
Clinical Trials on Interpersonal Therapy
-
Modum BadCompleted
-
University of California, San FranciscoMa'an OrganizationCompletedAnger | Depression | Domestic Violence | Post-Traumatic Stress DisorderEgypt
-
VA New York Harbor Healthcare SystemRecruitingDepression | AnxietyUnited States
-
Charlotte MorganCompletedChronic Low Back PainUnited Kingdom
-
University of Massachusetts, AmherstNational Institute of Mental Health (NIMH); University of ToledoCompletedBorderline Personality DisorderUnited States
-
Washington University School of MedicineCompletedBinge Eating Disorder | Cognitive Therapy/Methods | Mental Disorders/Epidemiology | Obesity/Epidemiology | Obesity/TherapyUnited States
-
Centre for Addiction and Mental HealthOntario Mental Health FoundationCompletedMajor DepressionCanada
-
Mayo ClinicCompletedBipolar Disorder, Depressed
-
Vanderbilt UniversityCompletedDepressive SymptomsUnited States
-
University of SaskatchewanRoyal University Hospital Foundation, Saskatoon, SK, CanadaUnknown